News
Nuravax, Institute for Molecular Medicine to present phase 1 results & phase 2 design of Alzheimer’s vaccine AV-1959R at CTAD 2025: Irvine, California Friday, July 4, 2025, 17:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback